Form 4 Tracker
TAKEDA PHARMACEUTICAL CO LTD
TAK

9 insider filings · Latest: Apr 27, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Dec 9, 2025Dec 9 11:05 AMLauren Rusckowski Duprey
Proposed Sale
29,619$14.22$421.2K

View →

Dec 5, 2025Dec 5 11:08 AMTeresa Marie Bitetti
Proposed Sale
87,023$14.28$1.2M

View →

Dec 4, 2025Dec 4 11:02 AMGiles Richard Platford
Proposed Sale
58,421$14.31$836.0K

View →

Jul 9, 2025Jul 9 10:45 AMThomas Wozniewski
Proposed Sale
6,136$15.42$94.6K

View →

Jul 9, 2025Jul 9 10:43 AMTeresa Marie Bitetti
Proposed Sale
52,649$15.42$811.8K

View →

Jul 9, 2025Jul 9 10:41 AMRamona A Sequeira
Proposed Sale
102,972$15.42$1.6M

View →

Jul 9, 2025Jul 9 10:38 AMMarcello Pignagnoli Agosti
Proposed Sale
18,622$15.42$287.2K

View →

Jul 9, 2025Jul 9 10:36 AMLauren Rusckowski Duprey
Proposed Sale
40,919$15.42$631.0K

View →

Jul 9, 2025Jul 9 10:34 AMJulie Kim
Proposed Sale
58,559$15.42$903.0K

View →

Jul 9, 2025Jul 9 10:32 AMGiles Richard Platford
Proposed Sale
28,552$15.42$440.3K

View →

Jul 9, 2025Jul 9 10:29 AMGabriele Ricci
Proposed Sale
26,874$15.42$414.4K

View →

Jul 9, 2025Jul 9 10:26 AMElaine Mary Shannon
Proposed Sale
4,477$15.42$69.0K

View →

Jul 9, 2025Jul 9 10:23 AMChristophe Pierre Weber
Proposed Sale
34,857$15.42$537.5K

View →

Jul 9, 2025Jul 9 10:20 AMAndrew Plump
Proposed Sale
169,313$15.42$2.6M

View →

Jul 9, 2025Jul 9 10:17 AMAkiko Amakawa
Proposed Sale
5,608$15.42$86.5K

View →

Aug 23, 2024Aug 23 12:36 AMGiles Richard Platford
Proposed Sale
19,073$14.94$285.0K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 27, 2026Apr 28 10:08 AMChristophe Pierre WeberDirector, President and CEO
Grant/Award
78,978125,345(D)

View →

Apr 27, 2026Apr 28 10:08 AMMilano FurutaDirector, Chief Financial Officer
Grant/Award
7,81416,619(D)

View →